These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18715472)

  • 1. Effects of early postnatal hyperglycaemia on renal cortex maturity, endothelial nitric oxide synthase expression and nephron deficit in mice.
    Cunha AR; Aguila MB; Mandarim-de-Lacerda CA
    Int J Exp Pathol; 2008 Aug; 89(4):284-91. PubMed ID: 18715472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic dyslipidaemia is associated with alterations in eNOS, caveolin-1, and endothelial dysfunction in streptozotocin treated rats.
    Shamsaldeen YA; Ugur R; Benham CD; Lione LA
    Diabetes Metab Res Rev; 2018 Jul; 34(5):e2995. PubMed ID: 29471582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tubular and glomerular L-arginine transport (uptake and transporters) and the nitric oxide synthases in ischemic acute renal failure (iARF) in streptozotocin-induced diabetic rats (STZ-DM).
    Levin-Iaina N; Schwartz I; Chernichovsky T; Davidovitch A; Iaina A; Schwartz D
    Ren Fail; 2007; 29(8):1031-8. PubMed ID: 18067052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of adrenomedullin and receptors in glomerular hyperfiltration in streptozotocin-induced diabetic rats.
    Hiragushi K; Wada J; Eguchi J; Matsuoka T; Yasuhara A; Hashimoto I; Yamashita T; Hida K; Nakamura Y; Shikata K; Minamino N; Kangawa K; Makino H
    Kidney Int; 2004 Feb; 65(2):540-50. PubMed ID: 14717924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal status affects the progression of STZ-induced diabetes and diabetic renal damage in the VCD mouse model of menopause.
    Keck M; Romero-Aleshire MJ; Cai Q; Hoyer PB; Brooks HL
    Am J Physiol Renal Physiol; 2007 Jul; 293(1):F193-9. PubMed ID: 17389681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of endothelial nitric oxide synthase in developing rat kidney.
    Han KH; Lim JM; Kim WY; Kim H; Madsen KM; Kim J
    Am J Physiol Renal Physiol; 2005 Apr; 288(4):F694-702. PubMed ID: 15572524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of TRPV4, eNOS and caveolin-1 contribute to endothelial dysfunction in the streptozotocin rat model of diabetes.
    Shamsaldeen YA; Lione LA; Benham CD
    Eur J Pharmacol; 2020 Dec; 888():173441. PubMed ID: 32810492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astragaloside IV protects against diabetic nephropathy via activating eNOS in streptozotocin diabetes-induced rats.
    Fan Y; Fan H; Zhu B; Zhou Y; Liu Q; Li P
    BMC Complement Altern Med; 2019 Dec; 19(1):355. PubMed ID: 31805910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glomerular eNOS gene expression during postnatal maturation and AT1 receptor inhibition.
    Ratliff B; Rodebaugh J; Sekulic M; Solhaug M
    Pediatr Nephrol; 2007 Aug; 22(8):1135-42. PubMed ID: 17437130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.
    Fang L; Radovits T; Szabó G; Mózes MM; Rosivall L; Kökény G
    Nephrol Dial Transplant; 2013 Jul; 28(7):1751-61. PubMed ID: 23203993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ASK1 Inhibitor Halts Progression of Diabetic Nephropathy in Nos3-Deficient Mice.
    Tesch GH; Ma FY; Han Y; Liles JT; Breckenridge DG; Nikolic-Paterson DJ
    Diabetes; 2015 Nov; 64(11):3903-13. PubMed ID: 26180085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin reduces proteinuria in streptozotocin-induced diabetic Wistar rats.
    Nakamaki S; Satoh H; Kudoh A; Hayashi Y; Hirai H; Watanabe T
    Exp Biol Med (Maywood); 2011 May; 236(5):614-20. PubMed ID: 21521713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Piperazine ferulate ameliorates the development of diabetic nephropathy by regulating endothelial nitric oxide synthase.
    Yang YY; Shi LX; Li JH; Yao LY; Xiang DX
    Mol Med Rep; 2019 Mar; 19(3):2245-2253. PubMed ID: 30664213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of renal nitric oxide synthase in diabetic kidney disease during the chronic phase of diabetes.
    Khamaisi M; Keynan S; Bursztyn M; Dahan R; Reinhartz E; Ovadia H; Raz I
    Nephron Physiol; 2006; 102(3-4):p72-80. PubMed ID: 16319502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effects of Dimethyl Fumarate on Atherosclerosis in the Apolipoprotein E-Deficient Mouse Model with Streptozotocin-Induced Hyperglycemia Mediated By the Nuclear Factor Erythroid 2-Related Factor 2/Antioxidant Response Element (Nrf2/ARE) Signaling Pathway.
    Luo M; Sun Q; Zhao H; Tao J; Yan D
    Med Sci Monit; 2019 Oct; 25():7966-7975. PubMed ID: 31645538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioprotective effects of atrasentan, an endothelin-A receptor antagonist, but not of nitric oxide in diabetic mice with myocyte-specific overexpression of endothelial nitric oxide synthase.
    Wölkart G; Stessel H; Saad Z; Kirchengast M; Brunner F
    Br J Pharmacol; 2006 Jul; 148(5):671-81. PubMed ID: 16702986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tubular and interstitial cell apoptosis in the streptozotocin-diabetic rat kidney.
    Kumar D; Zimpelmann J; Robertson S; Burns KD
    Nephron Exp Nephrol; 2004; 96(3):e77-88. PubMed ID: 15056984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine D
    Wang H; Yao Y; Liu J; Cao Y; Si C; Zheng R; Zeng C; Guan H; Li L
    Biochem Biophys Res Commun; 2019 Oct; 518(3):554-559. PubMed ID: 31447121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic diabetic nephropathy: role of inducible nitric oxide synthase.
    Trachtman H; Futterweit S; Pine E; Mann J; Valderrama E
    Pediatr Nephrol; 2002 Jan; 17(1):20-9. PubMed ID: 11793130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered endothelial nitric oxide synthase targeting and conformation and caveolin-1 expression in the diabetic kidney.
    Komers R; Schutzer WE; Reed JF; Lindsley JN; Oyama TT; Buck DC; Mader SL; Anderson S
    Diabetes; 2006 Jun; 55(6):1651-9. PubMed ID: 16731827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.